AMS:DSFIR - Euronext Amsterdam - CH1216478797 - Common Stock - Currency: EUR
AMS:DSFIR (3/7/2025, 7:00:00 PM)
96
-0.72 (-0.74%)
The current stock price of DSFIR.AS is 96 EUR. In the past month the price increased by 0.59%. In the past year, price decreased by -6.6%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
6D81.DE | DUPONT DE NEMOURS INC | 19.09 | 29.92B | ||
BRG.OL | BORREGAARD ASA | 21.84 | 18.00B | ||
ELK.OL | ELKEM ASA | 29.74 | 14.84B | ||
SY1.DE | SYMRISE AG | 34.09 | 13.39B | ||
1COV.DE | COVESTRO AG | N/A | 11.08B | ||
AKZA.AS | AKZO NOBEL N.V. | 15.78 | 10.49B | ||
EVK.DE | EVONIK INDUSTRIES AG | 27.39 | 10.08B | ||
AMC.DE | ALBEMARLE CORP | N/A | 8.33B | ||
SYENS.BR | SYENSQO SA | N/A | 7.47B | ||
AKE.PA | ARKEMA | 10.06 | 6.30B | ||
WCH.DE | WACKER CHEMIE AG | 30.92 | 4.02B | ||
NVJP.DE | UMICORE | N/A | 2.19B |
DSM-Firmenich AG is an innovator in nutrition, health, and beauty. The firm operates in four complementary businesses Perfumery & Beauty, which offer perfumery, fragrance ingredients and personal and care aroma; Taste, Texture & Health, which produces nutritional products with natural flavours and ingredients; Health, Nutrition & Care division offers customized products that contain vitamins, nutritional lipids, digestive enzymes, probiotics and cannabinoids (CBD); Animal Nutrition & Health business offers customer tailored products, solutions and services for animal farming that contain vitamins, animal proteins, carotenoids and premixes. The firm operates worldwide.
DSM-FIRMENICH AG
Wurmisweg 576, Kaiseraugst
Kaiseraugst AARGAU CH
Employees: 27926
Company Website: https://www.dsm-firmenich.com/corporate/home.html
Investor Relations: http://www.dsm-firmenich.com/corporate/investors/
The current stock price of DSFIR.AS is 96 EUR. The price decreased by -0.74% in the last trading session.
The exchange symbol of DSM-FIRMENICH AG is DSFIR and it is listed on the Euronext Amsterdam exchange.
DSFIR.AS stock is listed on the Euronext Amsterdam exchange.
31 analysts have analysed DSFIR.AS and the average price target is 133.09 EUR. This implies a price increase of 38.64% is expected in the next year compared to the current price of 96. Check the DSM-FIRMENICH AG stock analysts ratings, price target forecast and up-and down grades for more detailed information.
DSM-FIRMENICH AG (DSFIR.AS) has a market capitalization of 25.51B EUR. This makes DSFIR.AS a Large Cap stock.
DSM-FIRMENICH AG (DSFIR.AS) currently has 27926 employees.
DSM-FIRMENICH AG (DSFIR.AS) has a support level at 95.12 and a resistance level at 100.77. Check the full technical report for a detailed analysis of DSFIR.AS support and resistance levels.
The Revenue of DSM-FIRMENICH AG (DSFIR.AS) is expected to grow by 9.37% in the next year. Check the estimates tab for more information on the DSFIR.AS EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
DSM-FIRMENICH AG (DSFIR.AS) has a dividend yield of 2.58%. The yearly dividend amount is currently 0. Check the full fundamental report for a detailed analysis of DSFIR.AS dividend history, reliability and sustainability.
DSM-FIRMENICH AG (DSFIR.AS) will report earnings on 2025-04-30.
The PE ratio for DSM-FIRMENICH AG (DSFIR.AS) is 10.51. This is based on the reported non-GAAP earnings per share of 9.13 and the current share price of 96 EUR. Check the full fundamental report for a full analysis of the valuation metrics for DSFIR.AS.
ChartMill assigns a technical rating of 1 / 10 to DSFIR.AS. When comparing the yearly performance of all stocks, DSFIR.AS is a bad performer in the overall market: 83.96% of all stocks are doing better.
ChartMill assigns a fundamental rating of 4 / 10 to DSFIR.AS. DSFIR.AS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
Over the last trailing twelve months DSFIR.AS reported a non-GAAP Earnings per Share(EPS) of 9.13.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 20.05% | ||
ROA | 6.22% | ||
ROE | 9.3% | ||
Debt/Equity | 0.18 |
ChartMill assigns a Buy % Consensus number of 82% to DSFIR.AS. The Buy consensus is the average rating of analysts ratings from 31 analysts.
For the next year, analysts expect an EPS growth of 65.75% and a revenue growth 9.37% for DSFIR.AS